|
🦁
|
New diagnostic criteria for multiple sclerosis
H. Petereit,
Wolf D Heiss
|
8 |
2002 |
8
🦁
|
|
🐜
|
International quality control survey of neurochemical dementia diagnostics
25 auth.
P. Lewczuk,
G. Beck,
O. Ganslandt,
H. Esselmann,
F. Deisenhammer,
A. Regeniter,
H. Petereit,
H. Tumani,
A. Gerritzen,
P. Oschmann,
J. Schröder,
P. Schönknecht,
K. Zimmermann,
H. Hampel,
K. Bürger,
...
M. Otto,
Sabine Haustein,
Karin Herzog,
R. Dannenberg,
U. Wurster,
M. Bibl,
J. Maler,
Udo Reubach,
J. Kornhuber,
J. Wiltfang
|
6 |
2006 |
6
🐜
|
|
🐜
|
The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature
7 auth.
S. Jarius,
P. Eichhorn,
D. Franciotta,
H. Petereit,
G. Akman‐Demir,
M. Wick,
...
B. Wildemann
|
6 |
2016 |
6
🐜
|
|
🐜
|
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica
13 auth.
S. Jarius,
D. Franciotta,
R. Bergamaschi,
S. Rauer,
K. Wandinger,
H. Petereit,
M. Maurer,
H. Tumani,
A. Vincent,
P. Eichhorn,
...
B. Wildemann,
M. Wick,
R. Voltz
|
6 |
2008 |
6
🐜
|
|
🐜
|
Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
112 auth.
P. Rieckmann,
K. Toyka,
C. Bassetti,
K. Beer,
S. Beer,
U. Buettner,
M. Chofflon,
M. Götschi-Fuchs,
K. Hess,
L. Kappos,
J. Kesselring,
N. Goebels,
H. Ludin,
H. Mattle,
M. Schluep,
...
C. Vaney,
U. Baumhackl,
T. Berger,
F. Deisenhammer,
F. Fazekas,
M. Freimüller,
H. Kollegger,
W. Kristoferitsch,
H. Lassmann,
H. Markut,
S. Strasser‐Fuchs,
K. Vass,
H. Altenkirch,
S. Bamborschke,
K. Baum,
R. Benecke,
W. Brück,
D. Dommasch,
W. Elias,
A. Gass,
W. Gehlen,
J. Haas,
G. Haferkamp,
F. Hanefeld,
H. Hartung,
C. Heesen,
F. Heidenreich,
R. Heitmann,
B. Hemmer,
T. Hense,
R. Hohlfeld,
R. Janzen,
G. Japp,
S. Jung,
E. Jügelt,
J. Koehler,
W. Kölmel,
N. König,
K. Lowitzsch,
U. Manegold,
A. Melms,
J. Mertin,
P. Oschmann,
H. Petereit,
M. Pette,
D. Pöhlau,
D. Pohl,
S. Poser,
M. Sailer,
S. Schmidt,
G. Schock,
M. Schulz,
S. Schwarz,
D. Seidel,
N. Sommer,
M. Stangel,
E. Stark,
A. Steinbrecher,
H. Tumani,
R. Voltz,
F. Weber,
W. Weinrich,
Robert Weissert,
H. Wiendl,
H. Wiethölter,
U. Wildemann,
U. Zettl,
F. Zipp,
R. Zschenderlein,
G. Izquierdo,
A. Kirjazovas,
L. Packauskas,
D. Miller,
B. Koncan Vracko,
A. Millers,
A. Orologas,
M. Panellus,
C. Sindic,
M. Bratić,
A. Švraka,
N. Vella,
Z. Stelmasiak,
K. Selmaj,
H. Bartosik-Psujik,
K. Mitosek-Szewczyk,
E. Belniak,
A. Mochecka,
A. Bayas,
A. Chan,
P. Flachenecker,
R. Gold,
B. Kallmann,
V. Leussink,
M. Mäurer,
K. Ruprecht,
G. Stoll,
F. Weilbach
|
6 |
2004 |
6
🐜
|
|
🦁
|
Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis
8 auth.
H. Petereit,
D. Reske,
H. Tumani,
S. Jarius,
F. Markus Leweke,
D. Woitalla,
...
H. Pfister,
A. Rubbert
|
6 |
2010 |
6
🦁
|
|
🐬
|
Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system – value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis
D. Reske,
H. Petereit,
W. Heiss
|
5 |
2005 |
5
🐬
|
|
🐬
|
Successful use of rituximab in a patient with Churg–Strauss syndrome and refractory central nervous system involvement
J. Saech,
Kasia Owczarzyk,
Sylvia Rösgen,
H. Petereit,
M. Hallek,
A. Rubbert-Roth
|
5 |
2009 |
5
🐬
|
|
🦁
|
Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies
H. Petereit,
A. Perniok
|
5 |
2004 |
5
🦁
|
